Showing results (21-30 of 2,751) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|March 30, 2016
Impressions of pharmacogenomic testing among Certified Registered Nurse Anesthetists: a mixed-method studyDru Riddle, Mat Gregoski, Kathy Baker, et al.
Pharmacogenomics|March 30, 2016
Navigating pleiotropy in precision medicine: pharmacogenes from trauma to behavioral healthVicki Oberg, Jerome Differding, Morgan Fisher, et al.
Pharmacogenomics|May 28, 2016
UGT1A6- and UGT2B7-related valproic acid pharmacogenomics according to age groups and total drug concentration levelsDimitrios Chatzistefanidis, Leandros Lazaros, Katerina Giaka, et al.
Pharmacogenomics|June 2, 2016
Evidence for extensive pleiotropy among pharmacogenesMatthew T Oetjens, William S Bush, Joshua C Denny, et al.
Pharmacogenomics|June 2, 2016
Clinical and genetic predictors of dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes mellitusJazlina Liza Jamaluddin, Hasniza Zaman Huri, Shireene Ratna Vethakkan
Pharmacogenomics|April 5, 2016
Role of pharmacogenetics on deferasirox AUC and efficacyJessica Cusato, Sarah Allegra, Silvia De Francia, et al.
Pharmacogenomics|April 5, 2016
Evaluating the impact of missenses mutations in CYP2D6*7 and CYP2D6*14A: does it compromise tamoxifen metabolism?Maria Acsm Borba, Renato P Melo-Neto, Glauber M Leitão, et al.
Pharmacogenomics|April 6, 2016
CYP2B6 genotype-based efavirenz dose recommendations during rifampicin-based antituberculosis cotreatment for a sub-Saharan Africa populationJackson K Mukonzo, Ronald K Bisaso, Jasper Ogwal-Okeng, et al.
Pharmacogenomics|April 6, 2016
Pharmacokinetics and pharmacogenomics of β-lactam-induced neutropeniaAndrea Hahn, Tsuyoshi Fukuda, David Hahn, et al.
Pharmacogenomics|April 6, 2016
A genetic risk score is associated with statin-induced low-density lipoprotein cholesterol loweringMaarten Leusink, Anke H Maitland-van der Zee, Bo Ding, et al.
Pageof 276